Dr Eugenio Galindo

Dr. Eugenio Galindo Explains Adult T-Cell Cancer

Oncology specialist Dr. Eugenio Galindo provides a closer look at adult T-cell leukemia and lymphoma.

Adult T-cell leukemia or lymphoma is a rare but often aggressive form of cancer which can be found in the blood, lymph nodes, skin, and multiple other areas of the body. A renowned cancer specialist from South Texas, oncologist Dr. Eugenio Galindo provides a closer look at the disease.

“When found in the blood, adult T-cell cancer is known as leukemia,” reveals Dr. Eugenio Galindo, “and, when found in the lymph nodes, it’s known as lymphoma.”

Adult T-cell leukemia or lymphoma has been linked to human T-cell lymphotropic virus type 1, yet fewer than five percent of those diagnosed with the virus will go on to develop T-cell cancer, according to Dr. Eugenio Galindo. “Human T-cell lymphotropic virus type 1 is most prevalent,” he adds, “in the Caribbean, parts of Japan, and certain areas of South and Central America, as well as Africa.”

Four subtypes of adult T-cell leukemia or lymphoma have been identified. “These,” says Dr. Eugenio Galindo, “extend to acute, lymphomatous, chronic, and smoldering.”

Acute, or aggressive, adult T-cell leukemia or lymphoma often develops rapidly, according to the oncology specialist, with symptoms including fatigue, a skin rash, and enlarged lymph nodes in the underarms, neck, or groin. “Lymphomatous adult T-cell leukemia or lymphoma, meanwhile,” he continues, “is found chiefly in the lymph nodes, and may present as high white blood cell counts.”

Slower-growing, so-called chronic and smoldering adult T-cell leukemia or lymphoma cases can result in similar complaints, although smoldering cases, in particular, are often associated with only very mild symptoms.

According to Dr. Eugenio Galindo, depending on the subtype or suspected subtype, diagnosis may require the removal of a small sample of tumor tissue. “Known as a biopsy, a small sample of abnormal skin tissue may also be taken instead,” explains the expert. Such samples, he says, will then be examined on a cellular level under a powerful microscope.

Treatment for adult T-cell leukemia or lymphoma is often subtype-dependant. A combination of chemotherapy treatments-such as those developed for aggressive non-Hodgkin lymphomas or acute lymphoblastic leukemia-will often be employed in an attempt to fight the disease.

“Prognosis is better for those with a diagnosis of chronic or smoldering adult T-cell leukemia or lymphoma,” explains Dr. Galindo. In cases of acute or lymphomatous adult T-cell leukemia or lymphoma, however, sadly prognosis often remains poor owing to intrinsic chemoresistance and complications caused by hypercalcemia and profound immune deficiency, according to the oncology specialist.

Dr. Eugenio Galindo has been an oncologist serving the Rio Grande Valley area of South Texas for almost 30 years. “Almost three decades on, I remain wholly committed,” he adds, wrapping up, “to bringing the very latest in cancer screening, diagnosis, treatment, and care to the southernmost tip of the state.”

Dr. Eugenio Galindo Continues to Bring Latest in Cancer Treatment and Screening to South Texas

Texas oncology specialist Dr. Eugenio Galindo explains his drive to bring the latest in cancer screening and treatment to the southernmost tip of the state.

For almost 30 years, oncology specialist Dr. Eugenio Galindo has been dedicated to delivering superior cancer care and screening in and around the Rio Grande Valley area of South Texas. The head of McAllen Oncology, located in the Hidalgo County city of McAllen, Dr. Galindo offers a closer insight into his work, as he and his team celebrate more than six months at their all-new, cutting edge medical facility.

“I’m committed,” explains Dr. Galindo, “to bringing the very latest in cancer treatment and screening to South Texas.”

His clinic, he says, offers complete cancer care in one of the most state of the art facilities in southernmost Texas. “These facilities,” adds the specialist cancer doctor, “include an innovative community infusion center with private suites, plus a diagnostic imaging center, laboratory, and more.”

Dr. Eugenio Galindo and his team unveiled the all-new, cutting edge cancer center to more than 350 current and former patients and their families earlier this year. Opened to much fanfare in mid-January, the center’s unveiling was held in association with the city of McAllen’s Chamber of Commerce.

Also in attendance were a number of prominent local figures and other dignitaries, according to Dr. Galindo. “It was wonderful to be able to share our passion for cutting edge cancer treatment and the latest advances in cancer screening with members of the local community,” he explains.

Oncologist Dr. Galindo has previously offered a special insight into his decades-long career, provided a closer look at the Texas Medical Association, and has shared valuable information on key medical society memberships. The specialist has also looked at primary breast cancer risk factors, primary skin cancer risk factors, and has explained at length the importance of early cancer detection, diagnosis, and treatment.

Back in June, Dr. Galindo and the McAllen Oncology team celebrated National Cancer Survivors Day. First held in 1988, National Cancer Survivors Day is intended, he explains, to demonstrate that life after a cancer diagnosis can be a reality. “The annual event is held each June to celebrate, inspire, and support cancer survivors and those recently diagnosed with the disease,” he adds, wrapping up.

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.

For the latest from Dr. Eugenio Galindo and McAllen Oncology, visit https://www.facebook.com/McAllenOncology/.

Dr. Eugenio Galindo - History of the American Cancer Society

Dr. Eugenio Galindo Shares a Brief History of the American Cancer Society

Oncologist Dr. Eugenio Galindo takes a closer look at how the American Cancer Society’s more than 100-year history has helped to shape the organization.

Dr. Eugenio GalindoCancer specialist Dr. Eugenio Galindo of McAllen Oncology, based in the Rio Grande Valley area of South Texas, and dedicated to bringing the latest in cancer treatment and screening to the southernmost tip of the state, offers a brief history of the American Cancer Society. This comes as the nonprofit organization is awarded GuideStar Platinum Seal of Transparency status for sharing the measures of progress and results used to continually pursue its mission more than 100 years after the society was first founded.

“The American Cancer Society’s mission,” says Dr. Galindo, “is to save lives, celebrate lives, and to lead the fight for a world free of cancer.”

Currently, the American Cancer Society is funding and conducting research, supporting patients, sharing expert information, and spreading the word about cancer prevention. “They do so,” Dr. Galindo adds, “all so that we can live longer, and better.”

Established in 1913 by a team of just 15 people, including ten doctors, the organization was originally known as the American Society for the Control of Cancer. “At that time,” says Dr. Galindo, “a cancer diagnosis often meant near-certain death.”

Rarely spoken about in public, the disease was steeped in fear and denial. “The American Society for the Control of Cancer’s founders knew that raised public awareness was essential if progress was to be made in the fight against the disease,” adds Dr. Galindo.

A little over three decades later, in 1945, the American Society for the Control of Cancer became the American Cancer Society. “World War II was over, and this marked the beginning of a new era for the organization,” explains Dr. Galindo.

With focus shifting away from the war effort and back toward public health, the following year the newly renamed American Cancer Society successfully fundraised over $4 million, equivalent to more than $50 million in today’s money. “$1 million of the $4 million total was used to establish and fund the American Cancer Society’s groundbreaking research program,” Dr. Galindo reveals. The research program, he says, quickly began to bear fruit as support for the organization grew.

This included achieving the first temporary remission in a child with leukemia by utilizing the drug aminopterin. “This,” suggests Dr. Eugenio Galindo, “marked the birth of the modern era of chemotherapy for cancer treatment.”

In the more than 70 years since the cancer society’s research program started, American Cancer Society-funded researchers have contributed toward almost every major cancer research breakthrough made around the world. “During the same period, the American Cancer Society has invested a total of more than $4 billion into life-saving cancer research,” adds Dr. Galindo.

The organization has subsequently earned a GuideStar Platinum Seal of Transparency for voluntarily sharing the measures of progress and results which it uses to pursue its mission. “Organizations earn a GuideStar Platinum Seal of Transparency by choosing from a catalog of more than 900 expert-recognized metrics, or by creating a new metric which best fits their work,” Dr. Galindo explains.

With over 1.6 million organization profiles on file, almost 10 million annual website visitors, and utilizing more than 200 data partners, GuideStar is widely considered to be the world’s number one source of information surrounding nonprofit organizations.

“A nonprofit itself,” adds Dr. Galindo, wrapping up, “GuideStar says it’s dedicated to providing better data for better decisions, and for a better world.”

Dr. Eugenio Galindo - Cancer Awareness Initiatives

Dr. Eugenio Galindo Highlights Forthcoming Cancer Awareness Initiatives

Oncology specialist Dr. Eugenio Galindo highlights upcoming American and international cancer awareness months.

 

Dr. Eugenio GalindoA Rio Grande Valley area cancer specialist for almost 30 years, Dr. Eugenio Galindo is dedicated to bringing the latest in cancer treatment and screening to South Texas. Here, the oncologist highlights a number of upcoming monthly cancer awareness initiatives and provides a brief insight into the complete cancer care on offer at McAllen Oncology.

 

“September marks National Prostate Cancer Awareness Month, National Childhood Cancer Awareness Month, Ovarian Cancer Awareness Month, Gynecologic Cancer Awareness Month, and Leukemia and Lymphoma Awareness Month,” explains Dr. Galindo. “Following that, October is Breast Cancer Awareness Month, while November marks Lung Cancer Awareness Month and Pancreatic Cancer Awareness Month,” adds the oncology specialist.

 

National Prostate Cancer Awareness Month, also commonly referred to as National Prostate Health Month, is observed each September in North America, according to Dr. Galindo. “The initiative is both led and observed by doctors and health experts, health advocates, and individuals concerned with prostate health and prostate cancer,” he explains.

 

National Childhood Cancer Awareness Month or Childhood Cancer Awareness Month is another annual, nationwide and international health campaign held across the United States and overseas. The initiative is organized by major childhood cancer organizations. “The goal of Childhood Cancer Awareness Month is to increase awareness of pediatric cancer,” says Dr. Galindo, “as well as to raise funds for vital research into the causes, prevention, diagnosis, treatment, and cure of such diseases.”

 

Ovarian Cancer Awareness Month, Gynecologic Cancer Awareness Month, and Leukemia and Lymphoma Awareness Month each address research into and awareness of their respective cancers throughout the month of September, according to Dr. Galindo. “Similarly,” he continues, “Breast Cancer Awareness Month is an annual health campaign organized and observed by major breast cancer charities both in the United States and internationally each October.”

 

Dr. Galindo also touches briefly on Pancreatic Cancer Awareness Month. “Pancreatic cancer is the third leading cause of cancer-related death in the United States,” he reveals, “and is expected to become the second by 2020, which is why awareness initiatives such as Pancreatic Cancer Awareness Month are so important.”

 

Oncologist Dr. Galindo has previously shared details of Oral Cancer Awareness Month in April, Skin Cancer Awareness Month in May, and National Cancer Survivors Day in June, held annually on the first Sunday of the month. July, he has also revealed, plays host to UV Safety Awareness Month and Gastrointestinal Stromal Tumor Awareness Day. “A gastrointestinal stromal tumor is a form of tumor which occurs in the digestive tract, such as the stomach or small intestine,” he adds.

 

The oncology specialist has also written extensively on the subjects of breast cancer risk factors, the importance of early cancer detection, diagnosis, and treatment, melanoma warning signs, and more, as well as sharing an insight into his decades-long oncology career and prestigious medical society memberships.

 

“Earlier this year, my team and I moved operations at McAllen Oncology to our cutting edge new medical facility,” he adds, wrapping up, “where we’re now abler than ever to proudly offer complete cancer care in a true state of the art environment.”

 

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.

Dr. Eugenio Galindo - Chiropractic Medicare Coverage

Dr. Eugenio Galindo Marks Six Months at Groundbreaking New Cancer Facility

Dr. Eugenio Galindo

Cancer specialist Dr. Eugenio Galindo and his team celebrate six months at McAllen Oncology’s cutting edge new facility, first unveiled earlier this year.

Unveiled in January, Dr. Eugenio Galindo and McAllen Oncology’s cutting edge brand new cancer center is touted to be the only facility of its kind in South Texas, boasting state of the art facilities such as a diagnostic imaging center, plus an innovative community infusion center, private suites, its own laboratory, and more. Dr. Galindo looks back on the center’s grand opening earlier this year.

“My team and I were immensely proud to welcome almost 400 patients and their families to the grand opening of McAllen Oncology’s new cancer center at the beginning of the year,” reveals Dr. Galindo of the event which took place on January 11. A veteran of the field of oncology for more than 30 years, Dr. Eugenio Galindo staged the grand opening in association with the Texas city of McAllen’s famous Chamber of Commerce.

A number of prominent figures from the city also joined current and former patients for the event. “It was a fantastic day,” recalls Dr. Eugenio Galindo of the celebration six months ago. The oncology specialist and his team, from the all-new facility, are now able to offer what he calls complete care in a truly state of the art cancer center.

“We’ve now enjoyed six months at our new location on North G Street in McAllen,” he adds of the recent move, “proudly offering complete cancer care to patients in a truly state of the art facility.”

According to Dr. Galindo, the groundbreaking cancer center represents the only facility of its kind not just in McAllen, but across the whole of South Texas. The facility’s unveiling, ribbon cutting, and grand opening at the start of the year was held in association with the McAllen Chamber of Commerce. January also marked a similar event for the area’s Rio Grande Regional Hospital which broke ground during the first month of 2019.

Established in the mid-1920s, the McAllen Chamber of Commerce’s predecessor, the McAllen Businessmen’s Club, drove much of the initial development of the city of McAllen, according to Dr. Galindo. “The McAllen Chamber of Commerce is now the largest chamber in a 15 county area,” he points out, “and is widely regarded as the most progressive, most innovative, and most cutting edge chamber in the whole region, which is great news for the city.”

“It’s fitting, therefore,” adds Dr. Eugenio Galindo, wrapping up, “that we, at McAllen Oncology, also pride ourselves on our progressive, innovative, and cutting edge approach to cancer care here in southernmost Texas.”

Dr. Eugenio Galindo - Network Annual Report

Dr. Eugenio Galindo Awaits Next Month’s American Cancer Society Cancer Action Network Annual Report

Texas oncologist Dr. Eugenio Galindo looks toward American Cancer Society Cancer Action Network’s ‘How Do You Measure Up?’ report due to be published next month.

 

eugenio galindo
Eugenio Galindo

‘How Do You Measure Up?’ is an annual report compiled by the American Cancer Society Cancer Action Network, detailing where each U.S. state stands on critical issues impacting cancer patients and survivors. Oncology specialist Dr. Eugenio Galindo, who serves the Rio Grande Valley area of South Texas, reveals more about the upcoming report.

 

“Now in its 17th year, the 2019 American Cancer Society Cancer Action Network ‘How Do You Measure Up?’ report will be published next month,” Dr. Galindo explains.

 

The annual report, he says, focuses on preventing new cases of cancer, developing innovative cures and treatments, and ensuring that all cancer patients in America have access to the lifesaving medical care which they need. “State legislators play an essential role in this fight,” adds the cancer specialist.

 

According to respected oncology specialist Dr. Galindo, laws passed at state and local levels drastically help to improve the lives of both cancer patients and cancer survivors, and, supported by the work of the American Cancer Society Cancer Action Network, play a vital role in the nationwide fight against the disease.

 

The American Cancer Society Cancer Action Network is the nation’s leading cancer advocacy group, working to save lives through involvement, influence, and impact, according to the organization. “The American Cancer Society Cancer Action Network is a nonprofit, nonpartisan advocacy affiliate of the American Cancer Society,” Dr. Galindo further explains.

 

“The network works tirelessly to educate the public, elected officials, and candidates on cancer’s dreadful toll on public health, encouraging them to make the disease a top priority,” he adds.

 

Dr. Eugenio Galindo, meanwhile, is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost 30 years and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. The doctor has also authored several influential medical publications on the subject of oncology.

 

Last year’s 68-page American Cancer Society Cancer Action Network ‘How Do You Measure Up?’ report focused on access to care, increased access to Medicaid, cancer pain control, palliative care, and tobacco excise taxes, among numerous other important topics.

 

“The 2018 report also addressed breast and cervical cancer early detection programs and access to colorectal screening,” adds Dr. Galindo, wrapping up, “something which I hope to see more of in this year’s report, due to be published next month.”

 

‘How Do You Measure Up? A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, 2019’ will be published in August.

Dr. Eugenio Galindo - Melanoma Warning Signs

Dr. Eugenio Galindo Outlines Primary Melanoma Warning Signs

Oncologist Dr. Eugenio Galindo reveals key warning signs for the deadliest form of skin cancer.

 

eugenio galindo
eugenio galindo

The least common but most deadly form of skin cancer, more than 7,000 Americans will lose their lives to melanoma this year based on the latest estimates. A prominent cancer specialist serving the Rio Grande Valley area of South Texas, Dr. Eugenio Galindo outlines a number of key warning signs for the deadly disease.

 

“Melanoma accounts for only around one percent of all skin cancer cases, but the overwhelming majority of skin cancer deaths,” reveals Dr. Galindo.

 

This year, it’s estimated that, out of 96,480 newly diagnosed cases, 7,230 people in the United States will die as a result of melanoma, according to the AIM at Melanoma Foundation. “Despite incredible advances in cancer diagnosis, treatment, and research, melanoma continues to kill as many people as it did more than 30 years ago,” Dr. Galindo explains.

 

In fact, the number of diagnosed cases is up significantly in recent years, he says. “With this in mind, it’s more important than ever that people are familiar with the primary warning signs,” adds the cancer specialist, “of melanoma, especially as, when caught early, the disease is highly treatable.”

 

The American Cancer Society promotes what it calls the ‘ABCDE’ rule for identifying melanoma warning signs. A through E, these are asymmetry, border, color, diameter, and evolving. “Asymmetry is where a part of a mole doesn’t match the rest,” explains Dr. Galindo, “while border refers to watching for edges which become, or start to appear, irregular or blurred.”

 

“Color,” he continues, “should be similarly uniform, and if a mole appears to consist of different shades of brown or black, or there are patches of red, pink, blue, or white, there may be cause for concern.”

 

Of diameter, Dr. Galindo goes on to explain that where a mole, or another area of new skin discoloration, is larger than a quarter of an inch across, an expert opinion should be sought to rule out the possibility of melanoma. “The same,” he adds, “is true of moles or areas of discoloration which have become noticeably larger over time.”

 

Lastly, Dr. Galindo touches on what the American Cancer Society calls ‘evolving.’

 

“The spread of pigment into surrounding skin from a mole or spot, or any redness, represents what we call evolving,” he explains, “and must be investigated.”

 

Further to asymmetry and border, color, and diameter changes, plus the evolution of spots, moles, or other areas of discoloration of the skin, Dr. Galindo also highlights a number of further potential warnings signs. “A sore that won’t heal, unusual swelling, or sensation changes in the skin around moles or birthmarks should also be looked at,” he adds, “as should any tenderness, itchiness, bleeding, or pain.”

 

If an individual or a friend or family member observe any one or more of these symptoms in themselves or someone else, it’s important, says Dr. Eugenio Galindo, that they seek medical attention.

 

“Doing so could very well save your life,” he adds, wrapping up, “or the life of a much-loved family member or friend, so it’s essential to remain vigilant for the warning signs of melanoma.”

Dr. Eugenio Galindo - Gastrointestinal Stromal Tumor Awareness Day

Dr. Eugenio Galindo Reveals Details of Upcoming Gastrointestinal Stromal Tumor Awareness Day

Oncology specialist Dr. Eugenio Galindo shares details of annual Gastrointestinal Stromal Tumor Awareness Day, organized by the Life Raft Group.

Dr. Eugenio GalindoOn Sunday, July 13, 2014, the Life Raft Group celebrated the very first global Gastrointestinal Stromal Tumor Awareness Day. The mission of the group is to enhance survival and quality of life for people living with a gastrointestinal stromal tumor diagnosis through patient-powered research, education, empowerment, and global advocacy efforts. Oncologist Dr. Eugenio Galindo takes a closer look at the awareness initiative.

“In 2013, the Life Raft Group launched its ‘Rare 13’ campaign, highlighting and drawing attention to the fact that 13 people are diagnosed with gastrointestinal stromal tumors in the United States every day,” explains Dr. Galindo. Gastrointestinal Stromal Tumor Awareness Day has been held annually, on July 13, each year since.

A gastrointestinal stromal tumor is a form of tumor which occurs in the digestive tract, such as the stomach or small intestine. “Gastrointestinal stromal tumors are most often diagnosed in patients aged over 40,” reveals Dr. Galindo, “but, occasionally, younger adults and children may also develop such tumors.”

Around 5,000 new cases of gastrointestinal stromal tumor, also known as gastrointestinal stromal neoplasm and gastrointestinal stromal sarcoma, are currently diagnosed each year in the United States. “Prognosis and treatment options vary depending upon how quickly the cancer cells are growing, the size of the tumor, whether it has spread, and whether it can be completely removed via surgery,” Dr. Eugenio Galindo explains.

In addition to surgery, three further options are commonly made available to patients. These are targeted therapy, supportive care, and what’s known as watchful waiting, according to Dr. Galindo.

Gastrointestinal Stromal Tumor Awareness Day 2019 will be held on Saturday, July 13.

Dr. Galindo has previously shared details of Oral Cancer Awareness Month in April, Skin Cancer Awareness Month in May, and National Cancer Survivors Day in June, held annually on the first Sunday of the month. July, meanwhile, also plays host to UV Safety Awareness Month, the goal of which is to spread the word about how vital protection from the harmful effects of UV rays really is, and the link between excessive UV exposure and skin cancer.

Later in the year, September marks National Prostate Cancer Awareness Month, Childhood Cancer Month, Ovarian Cancer Awareness Month, Gynecologic Cancer Awareness Month, and Leukemia and Lymphoma Awareness Month. Next, October is National Breast Cancer Awareness Month, while November marks Lung Cancer Awareness Month and Pancreatic Cancer Awareness Month, according to Dr. Galindo.

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.

To learn more about Gastrointestinal Stromal Tumor Awareness Day and the Life Raft Group, visit https://liferaftgroup.org/about-gist-awareness-day/.

Eugenio Galindo

Dr. Eugenio Galindo looks toward UV Safety Awareness Month

Oncology specialist Dr. Eugenio Galindo reveals details of upcoming UV Safety Awareness Month.

With July marking UV Safety Awareness Month each year in the United States, Dr. Eugenio Galindo is keen to share details of the annual awareness initiative. A prominent oncology specialist serving the Rio Grande Valley area of South Texas, Dr. Galindo explains more about UV exposure and its links to skin cancer.

“It’s important to be safe in the sun,” says Dr. Galindo, “but there’s more to UV Safety Awareness Month than just this simple message.”

“The goal of UV Safety Awareness Month is to spread the word about how vital protection from the harmful effects of UV rays really is, not just in July, but year-round,” adds the oncologist.

UV light from the sun, as well as from tanning beds, is a form of radiation, classified by wavelength: UVA, UVB, and UVC. “All UVC light from the sun is blocked by the ozone layer, but not UVB or UVA,” reveals Dr. Galindo. Both UVA and UVB, he says, are closely associated with skin cancer development.

“What’s most surprising to many people, however,” says Dr. Galindo, “is that artificial UV light, such as that from tanning beds, is often the most dangerous, particularly in terms of causing cancer.”

Indeed, the American Academy of Dermatology suggests that tanning beds may be directly responsible for as many as 400,000 new cases of skin cancer in the United States each year.

According to the American Cancer Society, meanwhile, a total of more than 5 million basal skin cancer cases, and approximately 3.3 million squamous cell skin cancer cases are diagnosed annually, with excessive UV exposure playing a part in many.

“In addition to causing skin cancer, excessive UV exposure is also responsible for causing cataracts and other eye damage, premature aging of the skin, immune system suppression, and a variety of further health complaints and conditions,” Dr. Eugenio Galindo adds.

As such, he says, it’s important to ensure a level of protection from harmful UV rays wherever possible. “Avoid the bright midday sun, especially during the summer, stay away from indoor tanning beds, and always remember sunscreen,” advises the specialist cancer doctor.

UV Safety Awareness Month is promoted each July by the U.S. Department of Health and Human Services, the Centers for Disease Control and Prevention, the American Cancer Society, and the Oncology Nursing Society, as well as the U.S. Department of Veterans Affairs, and the U.S. Forest Service, among various other organizations.

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.

Dr. Eugenio Galindo- New Breast Cancer Drug

Dr. Eugenio Galindo Takes a Closer Look at New Breast Cancer Drug Tested in Texas

Oncologist Dr. Eugenio Galindo provides a professional look at a brand new advanced breast cancer drug, recently trialed in Texas.

 

eugenio galindo
eugenio galindo

A revolutionary new drug, recently tested in Texas, could provide help to tens of thousands of women living with advanced breast cancer, according to Dr. Eugenio Galindo. Touted to support the management of the disease, without reliance on painful, traditional treatments, such as intravenous chemotherapy, the oncology specialist provides a closer look at the recently trialed drug, known as alpelisib.

 

The drug, alpelisib, branded Piqray by pharmaceutical company Novartis, was approved by the U.S. Food and Drug Administration at the end of May. “Piqray has already demonstrated success in clinical trials, conducted, in part, here in the state of Texas,” explains Dr. Galindo, a prominent oncologist serving the Rio Grande Valley area of South Texas for almost 30 years.

 

According to the specialist, certain patients diagnosed with metastatic hormone receptor-positive breast cancer are likely eligible for treatment with the new drug. “It does remain, however, that only a specific subset of cancer patients, with PIK3CA gene mutation, are suitable,” adds Dr. Galindo, “yet this still represents many, many thousands of women who are diagnosed every year in the United States.”

 

Alpelisib is claimed by Novartis, as Piqray, to help manage advanced breast cancer. “The drug is designed to stop tumor growth,” Dr. Galindo explains, “allowing patients to live normal lives, without having to endure traditional and encumbering therapies, such as intravenous chemotherapy.”

 

Cancer treatments, he suggests, are, in general, moving in this direction. “Newer drugs, such as alpelisib, are targeted to specific tumor traits on a molecular level,” reveals the expert.

 

Combined with hormone therapy, recent Piqray trials carried out in Texas and elsewhere in the U.S. are reported by Novartis to demonstrate, potentially, almost doubled progression-free survival. “Furthermore, upwards of one-third of patients who partook in the trial witnessed their tumors shrink,” adds Dr. Galindo, “and, in some cases, disappear, according to Novartis.”

 

Novartis, or Novartis International AG, is a multinational pharmaceutical company based in Basel, Switzerland, and one of the world’s largest pharmaceutical companies by market capitalization and sales. Novartis is a member of the European Federation of Pharmaceutical Industries and Associations, the International Federation of Pharmaceutical Manufacturers and Associations, and Pharmaceutical Research and Manufacturers of America.

 

“Early results, as they pertain to alpelisib, or Piqray, are incredibly positive,” Dr. Galindo suggests, wrapping up, “which provides great hope for those diagnosed with various forms of breast cancer, today and in the future, and further demonstrates the critical importance of ongoing cancer research, both here in Texas and across America, as well as globally.”

 

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.